•  
  •  
  •  
  •  

2026-07-23 02:34:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Tanla Platforms Reports Strong Q1 FY27 Results with Net Profit Rising 20.1% YoY to ₹142 Crore
  • United Spirits Limited Reports Q1 FY27 Results with Consolidated Net Profit Rising to ₹463 Crore
  • Mahindra Lifespaces and Sumitomo Corporation strengthen partnership to expand Origins by Mahindra in Chennai
  • Waaree Renewable Technologies Delivers Strong Q1 FY27 Performance with 53.23% Revenue Surge to ₹924.25 Crore
  • Signatureglobal Homes Ltd acquires saleable area of 0.38 mn sq.ft

Keywords Selected:  Unit2

Stock Report

  • Jain Resource Recycling receives regulatory order following Unit-II fire accident; Operations temporarily paused
  • Concord Biotech Ltd successfully completes PPB and NDA inspection
  • PVUNL commissions Unit 2 of Patratu STPP, Phase 1
  • Eugia Pharma Specialities Ltd receives OAI classification from USFDA for Unit 2
  • TVS Srichakra Ltd approves capex of upto Rs. 210 crores
  • Neyveli Uttar Pradesh Power Ltd commissions Unit 2 of 1980 MW Ghatampur Thermal Power Project
  • Hi-Tech Pipes Commences Commercial Production at Sanand, Gujarat - Unit II - Phase II
  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • THDC India Ltd commissions Unit 2 of 660 MW of Khurja STPP
  • Lupin receives Form 483 with 4 observations from USFDA for Pithampur Unit-2
  • Neuland Laboratories Ltd receives EIR from USFDA for Unit 2 at Pashamylaram Village
  • Neuland Laboratories Ltd completes USFDA inspection at Unit 2
  • Ami Organics Limited, Unit II, Ankleshwar Unit in Gujarat is GMP compliant Unit by PMDA Japan
  • OneSource Specialty Pharma Ltd secures Brazilian GMP approval for its flagship facility Unit 2
  • OneSource Specialty Pharma Ltd updates on cGMP inspection by USFDA
  • NHPC Ltd completes trial run of Unit 2 of Parbati-II HE Project
  • Pokarna Engineered Stone Ltd restarts operations at Unit 2
  • Apitoria Pharma Pvt Ltd gets Form 483 with 10 observations from US FDA
  • Pokarna Engineered Stone Ltd announces temporary shutdown at Unit 2
  • Shilpa Pharma Lifesciences Ltd's Unit 2, Raichur, Karnataka has cleared the COFEPRIS-Mexico GMP Inspection
  • Shilpa Pharma Lifesciences Ltd, Unit 2, Raichur, Karnataka has cleared the ANVISA-Brazil GMP inspection
  • Godrej Industries' Chemicals Business signs agreement to acquire Unit II of Shree Vallabh Chemicals, Kheda
  • Eugia Pharma Specialities Ltd receives 7 observations from USFDA for Unit II
  • NTPC commissions Durgapur PP-III Unit-2 of 20 MW

Latest Post

  • Tanla Platforms Reports Strong Q1 FY27 Results with Net Profit Rising 20.1% YoY to ₹142 Crore
  • United Spirits Limited Reports Q1 FY27 Results with Consolidated Net Profit Rising to ₹463 Crore
  • Mahindra Lifespaces and Sumitomo Corporation strengthen partnership to expand Origins by Mahindra in Chennai
  • Waaree Renewable Technologies Delivers Strong Q1 FY27 Performance with 53.23% Revenue Surge to ₹924.25 Crore
  • Signatureglobal Homes Ltd acquires saleable area of 0.38 mn sq.ft


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025